Phase
Condition
Post-traumatic Stress Disorders
Treatment
Psilocybin 25mg
Psilocybin 15mg
Clinical Study ID
Ages 21-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Be a United States Military Veteran
Have at least a high-school level of education or equivalent (e.g. GED).
Have a current DSM-5 diagnosis of Post-traumatic Stress Disorder
Have a CAPS-5 total severity score of ≥23 at baseline
SSRIs will be allowable so long as participants are on a stable regimen for a periodof 3 months.
Concurrent psychotherapy is allowed if the type and frequency of the therapy hasbeen stable for at least 2 months prior to screening and is expected to remainstable during participation in the study.
Be medically stable as determined by screening for medical problems via a personalinterview, a medical questionnaire, a physical examination, an electrocardiogram (ECG), and routine medical blood and urinalysis laboratory tests
No use of hallucinogens in the past 3 months and no history of regular or frequentuse of hallucinogens
Exclusion
Exclusion Criteria:
General medical exclusion criteria:
Individuals who are pregnant or nursing; individuals who are of child-bearingpotential and sexually active who are not practicing a highly effective meansof birth control
Individuals with partners of childbearing potential who are sexually active andnot practicing a highly effective means of contraception
Cardiovascular conditions: coronary artery disease, stroke, angina,uncontrolled hypertension, a clinically significant ECG abnormality (e.g.,atrial fibrilation), prolonged QTc interval (i.e., QTc > 450 msec), artificialheart valve, or TIA in the past year • Systolic blood pressure (SBP) > 139 mmHG; diastolic blood pressure (DBP) > 89 mm HG; heart rate (HR) > 90 bpm.
Epilepsy with history of seizures
Insulin-dependent diabetes; if taking oral hypoglycemic agent, then no historyof symptoms of hypoglycemia
Psychiatric Exclusion Criteria:
Current or past history of meeting DSM-5 criteria for schizophrenia spectrum orother psychotic disorders (except substance/medication-induced or due toanother medical condition), or Bipolar I or II Disorder
Current or history within six months of meeting DSM-5 criteria for a moderateor severe alcohol, tobacco, caffeine, or other drug use disorder; if a regularsmoker, they must agree to use a nicotine patch on the day of dosing as smokingwill not be allowed on these sessions
Have a first degree relative with schizophrenia spectrum or other psychoticdisorders including substance/medication-induced or due to another medicalcondition
Risk for acute suicidality as determined by clinician judgment (C-SSRS)
Has a psychiatric condition which precludes the establishment of therapeuticrapport as evidenced by long-term patterns of unstable relationships, historyof significant stress-related paranoia, and identity disturbances
History of a medically significant suicide attempt
Current MAOI antidepressant use
Study Design
Connect with a study center
Baylor College of Medicine
Houston, Texas 77030
United StatesSite Not Available
Baylor College of Medicine
Houston 4699066, Texas 4736286 77030
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.